Creation Technologies | AI Transformation Index
Creation Technologies is among the most AI-durable businesses in a PE portfolio: its core value delivery is physical, certified, and deeply regulated, mean...

Overview
Creation Technologies is a high-reliability Electronics Manufacturing Services (EMS) provider that earns fee-for-service revenue by designing, assembling, testing, and managing supply chains for complex electronic assemblies delivered to blue-chip OEM customers in Aerospace & Defense, Medical Devices, and Tech Industrials.
Executive Summary
Creation Technologies is among the most AI-durable businesses in a PE portfolio: its core value delivery is physical, certified, and deeply regulated, meaning AI cannot substitute the outcome, disintermediate the company, or enable AI-native competitors to leapfrog the multi-year qualification requirements that anchor customer relationships. The trade-off is that AI also offers limited transformative upside — the business cannot use AI to dramatically expand throughput or enter new markets the way a knowledge-intensive services business could, so the investment thesis must rest on organic growth in defense/medical end markets, operational execution, and selective M&A rather than AI-driven margin transformation. For a PE sponsor, Creation Technologies warrants attention on AI primarily as a supply chain intelligence and NPI efficiency tool — meaningful but incremental — rather than as a platform for step-change value creation.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
56.6
Ciridae AI Score
Durability Rationale
Creation Technologies' durability rests on a foundation of physical irreplaceability: the company manufactures certified, tested electronic assemblies that require real factories, real certifications, and real supply chain execution — none of which AI can dissolve. The structural protection layer is exceptionally strong, with multi-year qualification cycles, ITAR controls, AS9100D and ISO 13485 requirements, and significant capital investment creating barriers that AI-native entrants simply cannot circumvent with software. Switching costs from embedded NPI relationships and program-level test fixture investments reinforce incumbent advantage, though competitive intensity among established EMS peers limits absolute pricing power and keeps moat strength at the strong-but-not-impenetrable level.
Opportunity Rationale
AI's reach into Creation Technologies is real but structurally narrow: the company's production function is predominantly physical, meaning AI touches support workflows — supply chain intelligence, NPI documentation, quoting, yield analytics — rather than the core value-creating activity on the factory floor. Within those workflows the magnitude of improvement can be meaningful, and better AI-driven component shortage prediction or faster engineering documentation could create competitive differentiation, but the fundamental throughput constraint is factory capacity, not cognitive labor. There is no order-of-magnitude transformation thesis here; this is an efficiency and margin enhancement story in the cognitive support layers, not a reimagining of the business model.
Key Risks
If A&D and medical OEMs consolidate their supply bases heavily toward mega-EMS providers (Jabil, Flex, Sanmina) with scale-driven AI supply chain advantages, Creation could lose its strong-niche positioning — the durability thesis assumes continued premium for high-reliability, low-to-medium volume specialization, which could erode if large players develop convincing high-mix capability.
The opportunity assessment assumes AI impact is limited to support workflows; if AI-enabled design automation (e.g., generative PCB layout, AI-driven DFM) dramatically accelerates OEM in-house engineering and reduces demand for Creation's NPI and design-for-manufacturing services, the higher-margin advisory layer of the business could compress faster than expected.
Company Overview
| Headquarters | Boston, Massachusetts, United States |
| Products / Services | Electronics manufacturing, Turnkey product design and development, Lean manufacturing and integration, Test strategy and development, Design for supply chain and value analysis/value engineering (VAVE), After-market service solutions and end-of-life (EOL) strategy, Design for manufacturing, Rapid response manufacturing, Electronics supplier services |
| Deal Partners |
PE / Ownership History
| Event | Details |
|---|---|
Proposal to acquire IEC Electronics Corporation June 28, 2021 | Creation Technologies, backed by Lindsay Goldberg, submitted a non-binding proposal to acquire IEC Electronics, aiming to create a leading high-complexity, low-to-medium volume electronics manufacturer with complementary geographic footprints. |
Acquisition of Applied Technical Services (ATS) Announced May 5, 2020 | Creation Technologies acquired ATS, expanding its manufacturing footprint in the USA, Canada, Mexico, and China, and enhancing capabilities in Aerospace & Defense, Medical, and Tech Industrial markets. |
Acquired by Lindsay Goldberg July 18, 2019 | Lindsay Goldberg acquired Creation Technologies from Birch Hill Equity Partners. The acquisition was structured as a plan of arrangement under the Business Corporations Act of British Columbia. |
Executives
| Name | Background |
|---|---|
Patrick Freytag Chief Executive Officer (CEO) | Joined Creation Technologies in August 2019 as CFO, led strategic transformation including three acquisitions and doubling revenues between 2019 and 2024. Previous Companies: VP of Finance at TRC Solutions (engineering and consulting firm), Sr. Director of Global FP&A at Crane Currency, roles in investment banking at Credit Suisse (New York) and Citizens Financial Group (Boston). |
Megan Melusky Chief Financial Officer (CFO) | CFO since 2021, previously VP of Financial Planning & Analysis and Senior VP of Finance at Creation. Over 25 years in financial, operational, and supply chain roles primarily in the medical device industry. Previous Companies: Vice President of Finance, Global Products and Supply Chain at Cardinal Health Medical Segment; Senior Director, FP&A, Global Operations at Medtronic Minimally Invasive Therapies Group; roles at Covidien and Tyco Healthcare. |
David Longshore Chief Operating Officer (COO) | COO responsible for leadership of all production sites and customer relationship alignment. Strong manufacturing and sales background; joined Creation through ProWorks acquisition in 2008. Previous Companies: Sales Representative and sales team manager at ProWorks and Arrow Electronics; General Manager of San Jose and Dallas Business Units at Creation. |
Todd Baggett Chief Commercial Officer (CCO) | Responsible for Business Development and Marketing Operations. Over 25 years in Electronics Manufacturing Services with multi-disciplinary and global experience. Previous Companies: Senior roles at EPIC Technologies (a NATEL Company) and Jabil before joining Creation in 2015. |
Stephen P. DeFalco Executive Chairman | Executive Chairman since September 2019. Former Partner at Lindsay Goldberg Private Equity; President and CEO of Crane & Co., a supplier of currency paper and anti-counterfeiting technology; CEO roles at MDS (NYSE), Senseonics (NYSE) where he remains Chairman, and PathoGenetix. Other Roles: President of PerkinElmer Instruments, strategy consultant at McKinsey & Company, product development leader at IBM. Board Memberships: Served on boards of Big Ass Solutions, Crane, Senseonics, MDS, PathoGenetix, BioProcessors, MIT Sloan School Americas Executive Board, and MIT Alumni Association Board. |
Lindsay Goldberg